146 related articles for article (PubMed ID: 35766982)
21. Rationalization of paclitaxel insensitivity of yeast β-tubulin and human βIII-tubulin isotype using principal component analysis.
Das L; Bhattacharya B; Basu G
BMC Res Notes; 2012 Aug; 5():395. PubMed ID: 22849332
[TBL] [Abstract][Full Text] [Related]
22. Tubulin isotype substitution revealed that isotype combination modulates microtubule dynamics in
Honda Y; Tsuchiya K; Sumiyoshi E; Haruta N; Sugimoto A
J Cell Sci; 2017 May; 130(9):1652-1661. PubMed ID: 28302908
[TBL] [Abstract][Full Text] [Related]
23. Electrostatic contributions to colchicine binding within tubulin isotypes.
Huzil JT; Barakat K; Tuszynski JA
Electromagn Biol Med; 2009; 28(4):355-64. PubMed ID: 20017626
[TBL] [Abstract][Full Text] [Related]
24. Possible Roles of Specific Amino Acids in β-Tubulin Isotypes in the Growth and Maintenance of Neurons: Novel Insights From Cephalopod Mollusks.
Ludueña RF
Front Mol Neurosci; 2022; 15():838393. PubMed ID: 35493322
[TBL] [Abstract][Full Text] [Related]
25. Interactions of halichondrin B and eribulin with tubulin.
Bai R; Nguyen TL; Burnett JC; Atasoylu O; Munro MH; Pettit GR; Smith AB; Gussio R; Hamel E
J Chem Inf Model; 2011 Jun; 51(6):1393-404. PubMed ID: 21539396
[TBL] [Abstract][Full Text] [Related]
26. Eribulin disrupts EB1-microtubule plus-tip complex formation.
O'Rourke B; Yang CP; Sharp D; Horwitz SB
Cell Cycle; 2014; 13(20):3218-21. PubMed ID: 25485501
[TBL] [Abstract][Full Text] [Related]
27. βII-tubulin and βIII-tubulin mediate sensitivity to peloruside A and laulimalide, but not paclitaxel or vinblastine, in human ovarian carcinoma cells.
Kanakkanthara A; Northcote PT; Miller JH
Mol Cancer Ther; 2012 Feb; 11(2):393-404. PubMed ID: 22180309
[TBL] [Abstract][Full Text] [Related]
28. Molecular insight of isotypes specific β-tubulin interaction of tubulin heterodimer with noscapinoids.
Santoshi S; Naik PK
J Comput Aided Mol Des; 2014 Jul; 28(7):751-63. PubMed ID: 24916062
[TBL] [Abstract][Full Text] [Related]
29. A label-free mass spectrometry method for relative quantitation of β-tubulin isotype expression in human tumor tissue.
Miller LM; Huang Yang CP; Xiao H; Isaac S; Sève P; Dumontet C; Band Horwitz S; Hogue Angeletti R
Proteomics Clin Appl; 2012 Oct; 6(9-10):502-6. PubMed ID: 22996942
[TBL] [Abstract][Full Text] [Related]
30.
Pallante L; Rocca A; Klejborowska G; Huczynski A; Grasso G; Tuszynski JA; Deriu MA
Front Chem; 2020; 8():108. PubMed ID: 32154219
[TBL] [Abstract][Full Text] [Related]
31. Preparation of a monoclonal antibody specific for the class I isotype of beta-tubulin: the beta isotypes of tubulin differ in their cellular distributions within human tissues.
Roach MC; Boucher VL; Walss C; Ravdin PM; Ludueña RF
Cell Motil Cytoskeleton; 1998; 39(4):273-85. PubMed ID: 9580378
[TBL] [Abstract][Full Text] [Related]
32. Detection of human betaV-tubulin expression in epithelial cancer cell lines by tubulin proteomics.
Verdier-Pinard P; Shahabi S; Wang F; Burd B; Xiao H; Goldberg GL; Orr GA; Horwitz SB
Biochemistry; 2005 Dec; 44(48):15858-70. PubMed ID: 16313188
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of an intermediate taxol binding site within microtubule nanopores and a mechanism for tubulin isotype binding selectivity.
Freedman H; Huzil JT; Luchko T; Ludueña RF; Tuszynski JA
J Chem Inf Model; 2009 Feb; 49(2):424-36. PubMed ID: 19434843
[TBL] [Abstract][Full Text] [Related]
34. Class III
Yahiro K; Matsumoto Y; Fukushi JI; Kawaguchi KI; Endo M; Setsu N; IIda K; Fukushima S; Nakagawa M; Kimura A; Oda Y; Nakashima Y
Anal Cell Pathol (Amst); 2018; 2018():8987568. PubMed ID: 30034996
[TBL] [Abstract][Full Text] [Related]
35. The roles of cys124 and ser239 in the functional properties of human betaIII tubulin.
Joe PA; Banerjee A; Ludueña RF
Cell Motil Cytoskeleton; 2008 Jun; 65(6):476-86. PubMed ID: 18435451
[TBL] [Abstract][Full Text] [Related]
36. Termination of Protofilament Elongation by Eribulin Induces Lattice Defects that Promote Microtubule Catastrophes.
Doodhi H; Prota AE; Rodríguez-García R; Xiao H; Custar DW; Bargsten K; Katrukha EA; Hilbert M; Hua S; Jiang K; Grigoriev I; Yang CH; Cox D; Horwitz SB; Kapitein LC; Akhmanova A; Steinmetz MO
Curr Biol; 2016 Jul; 26(13):1713-1721. PubMed ID: 27321995
[TBL] [Abstract][Full Text] [Related]
37. BetaIII-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability.
Kamath K; Wilson L; Cabral F; Jordan MA
J Biol Chem; 2005 Apr; 280(13):12902-7. PubMed ID: 15695826
[TBL] [Abstract][Full Text] [Related]
38. Identification of tubulin drug binding sites and prediction of relative differences in binding affinities to tubulin isotypes using digital signal processing.
Chen K; Huzil JT; Freedman H; Ramachandran P; Antoniou A; Tuszynski JA; Kurgan L
J Mol Graph Model; 2008 Nov; 27(4):497-505. PubMed ID: 18951052
[TBL] [Abstract][Full Text] [Related]
39. Eribulin targets a ch-TOG-dependent directed migration of cancer cells.
Chanez B; Gonçalves A; Badache A; Verdier-Pinard P
Oncotarget; 2015 Dec; 6(39):41667-78. PubMed ID: 26497677
[TBL] [Abstract][Full Text] [Related]
40. Microtubulin binding sites as target for developing anticancer agents.
Islam MN; Iskander MN
Mini Rev Med Chem; 2004 Dec; 4(10):1077-104. PubMed ID: 15579115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]